EFFERVESCENT POTASSIUM CHLORIDE- potassium bicarbonate and potassium chloride effervescent tablets for oral solution tablet, eff

Krajina: Spojené štáty

Jazyk: angličtina

Zdroj: NLM (National Library of Medicine)

Aktívna zložka:

POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152, CHLORIDE ION - UNII:Q32ZN48698), POTASSIUM BICARBONATE (UNII: HM5Z15LEBN) (POTASSIUM CATION - UNII:295O53K152), LYSINE HYDROCHLORIDE (UNII: JNJ23Q2COM) (LYSINE - UNII:K3Z4F929H6)

Dostupné z:

Qualitest Pharmaceuticals

INN (Medzinárodný Name):

POTASSIUM CHLORIDE

Zloženie:

POTASSIUM CHLORIDE 1.25 g

Spôsob podávania:

ORAL

Typ predpisu:

PRESCRIPTION DRUG

Terapeutické indikácie:

INDICATIONS AND USAGE: 1. For therapeutic use in patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication and in patients with hypokalemic familial periodic paralysis. 2. For prevention of potassium depletion when the dietary intake of potassium is inadequate in the following conditions: patients receiving digitalis and diuretics for congestive heart failure; hepatic cirrhosis with ascities; states of aldosterone excess with normal renal function; potassium-losing nephropathy, and certain diarrheal states. 3. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a normal dietary pattern. Serum potassium should be checked periodically, however, and, if hypokalemia occurs, dietary supplementation with potassium-containing foods may be adequate to control milder cases. In more severe cases supplementation with potassium salts may be indicated. CONTRAINDICATIONS: Potassium supp

Prehľad produktov:

HOW SUPPLIED: Effervescent Potassium/Chloride Tablets. Each tablet in solution provides 25 mEq potassium and chloride.

Stav Autorizácia:

unapproved drug other

Súhrn charakteristických

EFFERVESCENT POTASSIUM CHLORIDE- POTASSIUM BICARBONATE AND POTASSIUM
CHLORIDE
EFFERVESCENT TABLETS FOR ORAL SOLUTION TABLET, EFFERVESCENT
QUALITEST PHARMACEUTICALS
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
EFFERVESCENT POTASSIUM CHLORIDE
PACKAGE INSERT
DESCRIPTION: An oral potassium supplement. each effervescent tablet in
solution provides the
equivalent of 25 mEq (1865 mg) potassium chloride (supplied by 1.25 g
potassium chloride, 0.7 g
potassium bicarbonate and 1.5 g l-lysine monohydrochloride) with 0.77
g citric acid, FD and C Yellow
No. 6 (Sunset Yellow), FD and C Yellow No. 6 Lake as color additives,
natural and artificial flavor, and
saccharin.
CLINICAL PHARMACOLOGY: Potassium ion is the principal intracellular
cation of most body
tissues. Potassium ions participate in many essential physiological
processes, such as the maintenance
of intracellular tonicity, nerve impulse transmission, enzymatic
reactions in intermediary metabolism,
cardiac, skeletal and smooth muscle function, and the maintenance of
normal renal function.
Potassium depletion may occur whenever the rate of potassium loss
through renal excretion and/or loss
from the gastrointestinal tract exceeds the rate of potassium intake.
Potassium depletion usually
develops slowly as a result of lengthy therapy with oral diuretics,
primary or secondary
hyperaldosteronism, , diabetic ketoacidosis, or inadequate replacement
of potassium in patients on
prolonged parenteral nutrition. Depletion is additionally associated
with severe diarrhea, accompanied
by vomiting. Potassium depletion due to these causes is usually
accompanied by a concomitant loss of
chloride and is manifested by hypokalemia and metabolic alkalosis.
Potassium depletion may result in
fatigue, weakness, nausea, drowsiness, loss of appetite, edema,
oliguria, and chronic ileus with
distention. Potassium deficiency may be manifested by shal